PolyPeptide Group / Key word(s): AGMEGM01.04.2022 / 07:00 PolyPeptide publishes invitation to the annual General Meeting 2022Zug, 1 April 2022 - PolyPeptide Group AG (PolyPeptide), a global leader in peptide custom development and manufacturing, published today the invitation to its first annual General Meeting whic.
The market study done by Fact.MR gives exclusive information about how the market will grow. The study identifies crucial trends that are determining the growth of Metabolic Disorders Drug market. This newly published report sheds light on vital dynamics, such as the drivers, restraints, and opportunities for key ma.
<p><span>As volatility dropped to levels below the extraordinary peaks of the previous year, trading activity on SIX Swiss Exchange also stabilized in 2021. New all-time highs were reached by the Swiss Market Index SMI®, ending 20.3% higher than in the previous year. Facilitating capital raising with new offerings, SIX Swiss Exchange recorded five IPOs – including its first ever SPAC listing – while twelve new product issuers and three trading participants joined this year.</span></p>
EQS Group-Ad-hoc: PolyPeptide Group / Key word: Personnel
PolyPeptide Group appoints Neil Thompson as Director Global Sales and Marketing and member of the Executive Committee, succeeding Jan. | December 1, 2021
PolyPeptide Group / Key word(s): Personnel01-Dec-2021 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Media Release - ad hoc announcement pursuant to Art. 53 LRPolyPeptide Group appoints Neil Thompson as Director Global Sal.